National Bank Of Canada Viking Therapeutics, Inc. Transaction History
National Bank Of Canada
- $57.5 Billion
- Q1 2024
A detailed history of National Bank Of Canada transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 150 shares of VKTX stock, worth $7,951. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150Holding current value
$7,951% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
426Shares Held
63.1MCall Options Held
7.39MPut Options Held
5.13M-
Black Rock Inc. New York, NY8.27MShares$439 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.79MShares$413 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.59MShares$190 Million3.55% of portfolio
-
State Street Corp Boston, MA3.33MShares$176 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$123 Million0.02% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.07B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...